-
Signature
-
/s/ Lynn Haaland, Attorney-in-Fact
-
Issuer symbol
-
YOU
-
Transactions as of
-
05 Aug 2025
-
Net transactions value
-
-$656,294
-
Form type
-
4
-
Filing time
-
07 Aug 2025, 20:20:27 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Barkin Michael Z |
President, Director |
85 10TH AVE., 9TH FLOOR, NEW YORK |
/s/ Lynn Haaland, Attorney-in-Fact |
07 Aug 2025 |
0001571970 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
YOU |
Class A Common Stock |
Sale |
$365,603 |
-11,333 |
-35% |
$32.26 |
21,392 |
05 Aug 2025 |
Direct |
F1, F2, F3 |
| transaction |
YOU |
Class A Common Stock |
Sale |
$290,691 |
-8,667 |
-41% |
$33.54 |
12,725 |
05 Aug 2025 |
Direct |
F1, F3, F4 |
| transaction |
YOU |
Class C Common Stock |
Disposed to Issuer |
|
-20,000 |
-12% |
|
143,179 |
06 Aug 2025 |
Direct |
F3, F5 |
| transaction |
YOU |
Class A Common Stock |
Award |
|
+20,000 |
+157% |
|
32,725 |
06 Aug 2025 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
YOU |
Non-voting common units of Alclear Holdings, LLC |
Disposed to Issuer |
|
-20,000 |
-12% |
|
143,179 |
06 Aug 2025 |
Class A Common Stock |
20,000 |
|
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: